1. Homepage
  2. Equities
  3. Brazil
  4. Bolsa de Valores de Sao Paulo
  5. Dimed S.A. Distribuidora de Medicamentos
  6. Financials
    PNVL3   BRPNVLACNOR9

DIMED S.A. DISTRIBUIDORA DE MEDICAMENTOS

(PNVL3)
  Report
Delayed Bolsa de Valores de Sao Paulo  -  05/27 02:43:51 pm EDT
11.99 BRL   +1.10%
05/19Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/04DIMED S A DISTRIBUIDORA DE MEDICAMENTOS : Dados Econômico-Financeiros
PU
03/24Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the Full Year Ended December 31, 2021
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 2 5933 2791 9951 761--
Enterprise Value (EV)1 2 5933 0331 9191 8181 8901 932
P/E ratio -58,9x25,1x13,0x14,0x10,9x
Yield ------
Capitalization / Revenue 0,95x1,16x0,62x0,47x0,39x0,34x
EV / Revenue 0,95x1,08x0,59x0,49x0,42x0,37x
EV / EBITDA -13,5x6,75x7,08x7,98x6,49x
Price to Book --1,90x1,95x--
Nbr of stocks (in thousands) 135 480151 188149 751148 478--
Reference price (BRL) 19,621,813,311,911,911,9
Announcement Date 03/31/202003/23/202103/24/2022---
1 BRL in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 2 7252 8193 2253 7284 5095 154
EBITDA1 -224284257237297
Operating profit (EBIT)1 -93,5116228--
Operating Margin -3,32%3,60%6,12%--
Pre-Tax Profit (EBT)1 -53,383,2154--
Net income1 76,856,2122128128163
Net margin 2,82%1,99%3,77%3,45%2,83%3,16%
EPS2 -0,370,530,910,851,09
Dividend per Share2 ------
Announcement Date 03/31/202003/23/202103/24/2022---
1 BRL in Million
2 BRL
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1
Net sales1 805812777802894969
EBITDA1 71,037,539,967,079,439,7
Operating profit (EBIT) ------
Operating Margin ------
Pre-Tax Profit (EBT) ------
Net income1 18,519,722,615,723,224,2
Net margin 2,30%2,43%2,91%1,95%2,60%2,50%
EPS ------
Dividend per Share ------
Announcement Date 03/23/202105/17/202108/17/202111/17/202103/24/202205/11/2022
1 BRL in Million
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 ---56,8130171
Net Cash position1 -24675,8---
Leverage (Debt / EBITDA) --1,10x-0,27x0,22x0,55x0,57x
Free Cash Flow ------
ROE (Net Profit / Equities) -8,99%8,98%14,6%10,5%12,2%
Shareholders' equity1 -6241 3548801 2171 336
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share2 --7,016,09--
Cash Flow per Share ------
Capex1 ---101111116
Capex / Sales ---2,71%2,46%2,25%
Announcement Date 03/31/202003/23/202103/24/2022---
1 BRL in Million
2 BRL
Previous periodNext period
Estimates
Key data
Capitalization (BRL) 1 760 952 922
Capitalization (USD) 367 899 911
Net sales (BRL) 3 225 408 000
Net sales (USD) 673 855 218
Number of employees 8 646
Sales / Employee (BRL) 373 052
Sales / Employee (USD) 77 938
Free-Float 56,0%
Free-Float capitalization (BRL) 986 286 905
Free-Float capitalization (USD) 206 055 971
Avg. Exchange 20 sessions (BRL) 9 087 488
Avg. Exchange 20 sessions (USD) 1 898 566
Average Daily Capital Traded 0,52%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA